Editors:
- Provides the latest information on the validation status of each novel biomarker
- Covers the present debate on potential clinical use of newly discovered biochemical markers and on patentability of genetic information
- Chapter authors are experts on the particular cancer type
Part of the book series: Current Clinical Pathology (CCPATH)
Buy it now
Buying options
Tax calculation will be finalised at checkout
Other ways to access
This is a preview of subscription content, log in via an institution to check for access.
Table of contents (19 chapters)
-
Front Matter
About this book
Reviews
From the reviews:
“In this book on clinically significant biotargets in cancer research, every organ system is thoroughly represented with adequate overviews and precise details of the biotargets. … the book is intended specifically for clinicians in the field, including medical students, residents, pathologists, and oncologists. … This is a well-written book that attempts to provide a wide spectrum of current scientific information about the clinical management of oncologic patients based on molecular aspects. … this book achieves its objectives while remaining easy to read.” (Natalie Webster, Doody’s Review Service, October, 2012)
Editors and Affiliations
-
Chair of General Pathology, Department of Experimental Medicine, University of L’Aquila, L'Aquila, Italy
Mauro Bologna
Bibliographic Information
Book Title: Biotargets of Cancer in Current Clinical Practice
Editors: Mauro Bologna
Series Title: Current Clinical Pathology
DOI: https://doi.org/10.1007/978-1-61779-615-9
Publisher: Humana Totowa, NJ
eBook Packages: Medicine, Medicine (R0)
Copyright Information: Springer Science+Business Media, LLC 2012
Hardcover ISBN: 978-1-61779-614-2Published: 05 April 2012
Softcover ISBN: 978-1-4939-5946-4Published: 23 August 2016
eBook ISBN: 978-1-61779-615-9Published: 03 April 2012
Series ISSN: 2197-781X
Series E-ISSN: 2197-7828
Edition Number: 1
Number of Pages: XVI, 564
Topics: Pathology, Oncology, Laboratory Medicine